: The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases / Manfredi, Mariangela; Van Hoovels, Lieve; Benucci, Maurizio; De Luca, Riccardo; Coccia, Carmela; Bernardini, Pamela; Russo, Edda; Amedei, Amedeo; Guiducci, Serena; Grossi, Valentina; Bossuyt, Xavier; Perricone, Carlo; Infantino, Maria. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - ELETTRONICO. - 13:(2023), pp. 688-690. [10.3390/jpm13040688]

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases

De Luca, Riccardo;Coccia, Carmela;Bernardini, Pamela;Russo, Edda;Amedei, Amedeo;Guiducci, Serena;
2023

Abstract

: The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.
2023
13
688
690
Manfredi, Mariangela; Van Hoovels, Lieve; Benucci, Maurizio; De Luca, Riccardo; Coccia, Carmela; Bernardini, Pamela; Russo, Edda; Amedei, Amedeo; Guid...espandi
File in questo prodotto:
File Dimensione Formato  
jpm-13-00688-v2.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 658.76 kB
Formato Adobe PDF
658.76 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1309232
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact